Stratos Wealth Partners LTD. Sells 2,740 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Stratos Wealth Partners LTD. lessened its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 17.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,560 shares of the company’s stock after selling 2,740 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in AdaptHealth were worth $120,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Blue Trust Inc. increased its stake in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the period. Quarry LP boosted its holdings in AdaptHealth by 4,596.9% during the third quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after purchasing an additional 5,838 shares in the last quarter. CIBC Asset Management Inc acquired a new stake in AdaptHealth during the third quarter valued at approximately $122,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares during the period. Finally, LRI Investments LLC raised its holdings in shares of AdaptHealth by 32.0% in the 3rd quarter. LRI Investments LLC now owns 15,331 shares of the company’s stock worth $172,000 after buying an additional 3,713 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Down 1.7 %

Shares of NASDAQ AHCO opened at $8.78 on Friday. AdaptHealth Corp. has a 12-month low of $7.01 and a 12-month high of $11.90. The firm’s 50-day simple moving average is $9.95 and its 200 day simple moving average is $10.28. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The company has a market cap of $1.18 billion, a price-to-earnings ratio of -5.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on AHCO. Royal Bank of Canada lowered their price target on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. UBS Group reduced their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday. Truist Financial dropped their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, November 15th. Robert W. Baird reduced their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Finally, Canaccord Genuity Group dropped their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 6th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $12.20.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.